Skip to navigation menu Skip to content
Illustration of a calendarIllustration of a document pageIllustration of a heart over a handIllustration of an envelopeIllustration of the letter i inside a circleIllustration of a map markerIllustration of a caduceusIllustration of a user with a plus signIllustration of a telephoneIllustration of a question mark inside a circleIllustration of a video cameraDocument with a PDF label
Clinical Trial Search block Test

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed with Crohn's Disease

CAMEO

  • Condition(s): Other
  • Clinicaltrials.gov ID: NCT05781152

What is the goal of the study?

With the CAMEO study we will focus on patients receiving optimized anti-TNF therapy within 180 days of diagnosis by utilization of frequent drug level monitoring and pharmacokinetic based dosage guidance, formalizing intestinal re-evaluation at standardized time-points with central adjudication, and fully characterizing the biologic profile of all participants.

Who can participate in the study?

Everyone

Study Team: